For decades, healthcare has operated in silos. The diagnostic lab discovers a cancer mutation. The data scientist identifies a pattern. The oncologist prescribes treatment. Each brilliant in their domain. Each [...]

How the NHS is leading a global revolution in precision diagnostics The Challenge The UK healthcare system faces unprecedented pressure. Prostate cancer has overtaken breast cancer as England's most common [...]

The landscape of precision diagnostics in the United Kingdom is undergoing a fundamental transformation. As we progress through 2026, three major developments are converging to redefine how diseases are detected, [...]

The UK’s health data ecosystem is entering a new phase, one where population health is no longer analysed solely in hindsight, but increasingly anticipated through predictive intelligence. At the centre [...]

Off-the-Shelf Immune Cell Therapy Hunts Down Pancreatic Cancer in Breakthrough Study Scientists have developed an “off-the-shelf” cell therapy that can seek out and destroy aggressive tumour cells, showing remarkable success [...]

FDA Approves New IsoPSA Blood Test to Pinpoint Aggressive Prostate Cancer The FDA has approved a novel blood test called IsoPSA that helps pinpoint aggressive prostate cancer in men over [...]

New Horizons in Targeted Therapeutics and Translational Medicine Advanced AI tools and biomarker innovations are unveiling hidden disease markers at the cellular level, fueling a new wave of precision [...]

Natera is deepening its footprint in precision oncology with the acquisition of Foresight Diagnostics in an all-stock deal worth up to $450 million. This move brings together Natera’s personalised [...]